2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow LY 2275796: new trials by email Literature Review of LY 2275796 trials Research Report on LY 2275796
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer ISIS 183750, Irinotecan - Colorectal Neoplasms, Colorectal Carcinoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 24 | 2012-08-01 | 2016-04-25 |
| LY2275796 in Advanced Cancer LY2275796 - Advanced Cancers | Phase 1 | Completed | M.D. Anderson Cancer Center | 24 | 2006-09-01 | 2012-07-30 |
M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1)
United States (2)
David Hong, MD (1) · Tim F Greten, M.D. (1)